secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001104659-24-025580
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics grants performance stock units to CEO, CFO, and CMO
--------------------------------------------------------------------------

- CEO Lisa Ricciardi awarded 150,000 PSUs vesting on clinical milestone achievement.
- CFO John Doyle awarded 60,000 PSUs; CMO Anthony Caggiano awarded 130,000 PSUs.
- PSUs vest in two equal installments one year after each milestone is met.
- Grants made under the 2021 Equity Incentive Plan; no executive departure or appointment.
- Compensatory arrangement with no change in company leadership or strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924025580/0001104659-24-025580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924025580/tm246515d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-025580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer